Theranostics · 2020 · 70 citations · 33 references
MedicineMolecular BiologyOncologyCell SignalingMolecular OncologySignal TransductionAstrocyte BiologyCancer Cell SignalingCancer Stem CellsGlioblastomaOncogenic Signaling PathwaysTargeted Cancer TherapyCancer Stem-like CellsGlioblastoma Drug TherapyGlioblastoma Stem CellsGlioblastoma Targeted TherapyGlioblastoma Tumor BiologyPi3k SignalingPrimary Brain NeoplasmsRna Sequencing (Rna-seq)
Our data demonstrate AEBP1 as a new druggable target in GBM and ACT001 as a potential therapeutic option for improving the clinical treatment of GBM in combination with SHP099.
33
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao, Qiulian Wu, Roger E. McLendon et al. · Nature · 2006 · 6.4K citations
Medicine, Cancer Biology, Oncology +16
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen, Matthew J. LaMarche, Ho Man Chan et al. · Nature · 2016 · 929 citations